ACS Journal Cancer
@JournalCancer
An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
ID:19077568
http://canceronlinejournal.com 16-01-2009 18:00:37
10,9K Tweets
29,6K Followers
4,5K Following
Follow People
👉👉👉Delighted to share our recent review in ACS Journal Cancer led by Dr .Wei Ying Jen |Tagraxofusp, a first‐in‐class #CD123 ‐targeted agent:Five‐year postapproval comprehensive review of the literature #BPDCN #endcancer MD Anderson Cancer Center acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
New study from American Cancer Society found that nearly 60% of working-age #CancerSurvivors report at least 1 type of financial hardship, such as being unable to afford medical bills, distress and worry, or delaying/forgoing care because of cost.
acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…
OncoAlert
A new study from Brooke Worster et al reveals that #SupportiveOncology is associated with reduced admissions, emergency department visits, and total costs in advanced cancer patients.
Read the #OpenAccess report: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
OncoAlert Yael Schenker #PallOnc
Just published & available #OpenAccess | Top advances of the year: Cervical cancer
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
The year 2023 was an extraordinary year for the further development and expansion of novel treatments for all patients with #CervicalCancer , ranging from early stage to
A new study from Università di Padova researchers reveals that regular #aspirin use may have an active role in enhancing immunosurveillance against #ColorectalCancer .
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
OncoAlert Wiley Oncology & Hematology #CRCSM
Fear of cancer recurrence remains unaddressed in guidelines for managing anxiety and depression in adult cancer survivors in the US. Daniel Hall, PhD and colleagues stress the need for these guidelines to ensure comprehensive psychosocial care.
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
OncoAlert
New & available #OpenAccess | The results of DREAMM-4 demonstrated clinical activity and a favorable safety profile of belamaf plus pembrolizumab in patients with relapsed or refractory multiple myeloma. Ajay Nooka, MD, MPH OncoAlert #mmsm acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
New from Tel Aviv University and Sheba Medical Center investigators | Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
OncoAlert Ruth O'Regan
The addition of daratumumab to the standard of care for patients with newly diagnosed #MultipleMyeloma significantly improved progression-free survival, reducing disease progression by 58% at 4 years.
Read more in our latest CancerScope: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…
Patient preferences should be considered when making shared decisions about cancer therapy. In this analysis, City of Hope researchers explore outcome prioritization among older adults with cancer.
#OpenAccess link: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
Enrique Soto
OncoAlert
Parental social functioning is an indicator of well-being in early bereavement. Preparation for end of life and absence of household material hardships was associated with parental social functioning.
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
Jennifer Snaman Abby Rosenberg, MD, MS, MA OncoAlert
its said that if you want to go fast go alone and
if you want to go far, go together
Our deepest gratitude to OUR 🚨PARTNERS
STRONGER TOGETHER‼️
ASTRO 🇺🇸
European Cancer Organisation 🇪🇺
American Cancer Society 🇺🇸Journals
➡️ACS Journal Cancer CA: A Cancer Journal for Clinicians 🇺🇸
MASCC 🌐
ABC Global Alliance
The OncoAlert🚨NEWSLETTER OUT‼️
Covering April 12-18, 2024
REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…
COVERING
✅NEW Prostate #cancer guidelines European Association of Urology (EAU)
✅The Lancet #BreastCancer Commission
✅1st line Pembro & cemiplimab in🫁 #NSCLC 🧪
✅RADICALS RT ☢️in
Thanks AACR for the profile. Hope all #immunotherapy & #immunology interested folks will join the Cancer Immunology Working Group (CIMM), particularly on LinkedIn for on-going discussions of the field!
This new review article from Wei Ying Jen, Marina Konopleva, & Naveen Pemmaraju, MD is all about #tagraxofusp for #BPDCN . Learn how it is being used in combination to improve outcomes in BPDCN & AML, & its developing role in other hematological malignancies: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert